Structural Challenges in South Africa’s Health Technology Sector
South Africa’s health technology landscape is marked by significant structural dependencies and inefficiencies. The sector heavily relies on imports, undermining its operational effectiveness. This dependency is evident in many district hospitals where essential technologies, often imported or donated, are rendered useless due to insufficient maintenance capabilities.
Recurring Issues in Healthcare Delivery
On April 21st, in honor of World Creation and Innovation Day, it’s essential to highlight common experiences many South Africans face in healthcare settings. Patients frequently encounter malfunctioning medical equipment, such as blood pressure cuffs that fail to operate or X-ray machines that are out of service. Such incidents are not isolated; they reflect chronic inefficiencies within a health system that allocates billions to technology that fails to deliver practical value, largely because it is manufactured abroad and not adapted for local needs.
The Scope of Medical Technology in Healthcare
Medical technology encompasses a vast array of instruments and devices designed to prevent, diagnose, monitor, and treat health conditions. From essential items like thermometers to sophisticated machinery such as MRI machines and AI-driven diagnostic platforms, the sector’s reliance on imports is stark. Valued between R21 billion and R29 billion in 2021, it is estimated that around 90% of products in South Africa’s medical technology market are imported, predominantly purchased by the government. This situation mirrors trends in many low- and middle-income countries, where approximately 95% of medical equipment is sourced from abroad and often funded by international donors.
The Consequences of Import-Heavy Models
However, this import-driven model presents limited benefits. The World Health Organization reports that 50% to 80% of medical equipment in under-resourced health systems is malfunctioning at any given time. Particularly concerning is the fact that between 40% and 70% of donated equipment remains unused due to poor suitability, lack of necessary training, and inadequate maintenance. This results in an accumulation of what has been described as a “medical equipment graveyard.”
Stumbling Blocks to Innovation
Research conducted by two recent PhD graduates from the Innovation Systems Research Program at Stellenbosch University, Dr. Maureen Etuket and Dr. Tinashe Chiknichawa, elucidates why advanced technologies fail to translate into practical solutions for widespread patient care. Their findings reveal recurrent barriers faced by innovators, irrespective of the quality of technology or effort invested.
Addressing Financial and Regulatory Hurdles
The first major barrier is misaligned funding timing. While South Africa invests in innovation, available funds often don’t align with the development timeline of medical devices. As highlighted by Etuket’s survey of 90 stakeholders, funding arrives early, vanishes during higher-risk phases, and reappears only once risks have diminished. This pattern often leads to halted projects at critical phases of development. There is a pressing need to establish a mission-driven funding pathway guided by the device development lifecycle.
Navigating Regulatory and Market Challenges
The regulatory landscape presents another significant obstacle. While the rules themselves are not inherently problematic, the lack of clear navigational guidance can be daunting for local innovators. Small-scale developers frequently find themselves overwhelmed by complex requirements, hampering their progress. Instead of eliminating regulations, there is a need for support mechanisms that help innovators effectively maneuver through the regulatory process in real time.
Connecting Development with Clinical Needs
Another critical barrier stems from disconnects between developers and the actual clinical needs within the public sector. Medical technology ventures often begin in the private sector due to slow public procurement processes, which are generally risk-averse and tailored for established products. Consequently, technologies may be refined in environments that do not reflect public sector requirements, resulting in products that are misaligned with the needs of public healthcare systems.
Incorporating Health Technology Assessment Early
The absence of health technology assessment (HTA) strategies further exacerbates the problem. HTA is crucial for understanding which technologies are effective, their cost implications, and their impact on patient care. Currently, HTA insights arrive too late in South Africa’s medical technology development process, often leading to inadequate evidence for technology adoption. Integrating HTA capabilities from the onset can create a more robust foundation for evidence-based decision-making in procurement processes.
Moving Towards a Cohesive Health Technology Ecosystem
The synthesis of these insights suggests a need for systemic interventions that enhance the connectivity of existing resources rather than simply adding new components. By fostering visibility into clinical needs and procurement criteria, incorporating HTA earlier in the innovation cycle, and aligning funding with device lifecycles, South Africa can build a more effective health technology ecosystem. By nurturing local talents and developing structured entry routes for public-sector procurement, we can ensure that innovative technologies fulfill the real healthcare needs of the population.
Sara Grobbelaar serves as a professor in the Department of Industrial Engineering at Stellenbosch University.
